These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

303 related articles for article (PubMed ID: 17710683)

  • 1. Successful resection of a giant recurrent gastrointestinal stromal tumour with imatinib mesylate as neoadjuvant therapy.
    Yu JR; Yang XJ; Yang WL; Gao Y; Zhang Q
    Scand J Gastroenterol; 2007 Sep; 42(9):1138-40. PubMed ID: 17710683
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Surgical resection of gastrointestinal stromal tumors after treatment with imatinib.
    Andtbacka RH; Ng CS; Scaife CL; Cormier JN; Hunt KK; Pisters PW; Pollock RE; Benjamin RS; Burgess MA; Chen LL; Trent J; Patel SR; Raymond K; Feig BW
    Ann Surg Oncol; 2007 Jan; 14(1):14-24. PubMed ID: 17072676
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Surgery and imatinib in the management of GIST: emerging approaches to adjuvant and neoadjuvant therapy.
    Eisenberg BL; Judson I
    Ann Surg Oncol; 2004 May; 11(5):465-75. PubMed ID: 15123459
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Gastrointestinal stromal tumours.
    Connolly EM; Gaffney E; Reynolds JV
    Br J Surg; 2003 Oct; 90(10):1178-86. PubMed ID: 14515284
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Decrease of CD117 expression as possible prognostic marker for recurrence in the resected specimen after imatinib treatment in patients with initially unresectable gastrointestinal stromal tumors: a clinicopathological analysis.
    Mearadji A; den Bakker MA; van Geel AN; Eggermont AM; Sleijfer S; Verweij J; de Wilt JH; Verhoef C
    Anticancer Drugs; 2008 Jul; 19(6):607-12. PubMed ID: 18525320
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Surgical treatment of patients with initially inoperable and/or metastatic gastrointestinal stromal tumors (GIST) during therapy with imatinib mesylate.
    Rutkowski P; Nowecki Z; Nyckowski P; Dziewirski W; Grzesiakowska U; Nasierowska-Guttmejer A; Krawczyk M; Ruka W
    J Surg Oncol; 2006 Mar; 93(4):304-11. PubMed ID: 16496358
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Management of gastrointestinal stromal tumors in the imatinib era: selected case studies.
    Benjamin RS; Blanke CD; Blay JY; Bonvalot S; Eisenberg B
    Oncologist; 2006 Jan; 11(1):9-20. PubMed ID: 16401709
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Gastric GISTs. Personal experience.
    Mingolla GP; Riccio PA; Linguerri R; La Donna M; Zannelli M; Artuso S
    Ann Ital Chir; 2007; 78(4):283-8; discussion 288-9. PubMed ID: 17990602
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Long-term follow-up outcome of imatinib mesylate treatment for recurrent and unresectable gastrointestinal stromal tumors.
    Saito S; Nakata K; Kajiura S; Ando T; Hosokawa A; Sugiyama T
    Digestion; 2013; 87(1):47-52. PubMed ID: 23343969
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A pilot study of imatinib mesylate (STI571) on gastrointestinal stromal tumors in Japanese patients.
    Sawaki A; Yamao K; Nakamura T; Suzuki T; Okubo K; Hara K; Kawai H; Yamamura Y; Ito S; Mochiduki Y; Ohno R
    J Gastroenterol; 2004; 39(4):329-33. PubMed ID: 15168243
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Management of localized gastrointestinal stromal tumors and adjuvant therapy with imatinib.
    López RL; del Muro XG
    Anticancer Drugs; 2012 Jun; 23 Suppl():S3-6. PubMed ID: 22739667
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [GIST: our experience].
    Rossi MT; Fasano G; Morlino A; Scutari F
    G Chir; 2009; 30(1-2):41-5. PubMed ID: 19272232
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Imatinib mesylate acts in metastatic or unresectable gastrointestinal stromal tumor by targeting KIT receptors--a review.
    Sawaki A; Yamao K
    Cancer Chemother Pharmacol; 2004 Sep; 54 Suppl 1():S44-9. PubMed ID: 15309514
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Neoadjuvant, adjuvant and palliative treatment of gastrointestinal stromal tumours (GIST) with imatinib: a centre-based study of 17 patients.
    Bümming P; Andersson J; Meis-Kindblom JM; Klingenstierna H; Engström K; Stierner U; Wängberg B; Jansson S; Ahlman H; Kindblom LG; Nilsson B
    Br J Cancer; 2003 Aug; 89(3):460-4. PubMed ID: 12888812
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Role of imatinib mesylate (Gleevec/Glivec) in gastrointestinal stromal tumors.
    de Jong FA; Verweij J
    Expert Rev Anticancer Ther; 2003 Dec; 3(6):757-66. PubMed ID: 14686698
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Is there a role of surgery in patients with recurrent or metastatic gastrointestinal stromal tumours responding to imatinib: a prospective randomised trial in China.
    Du CY; Zhou Y; Song C; Wang YP; Jie ZG; He YL; Liang XB; Cao H; Yan ZS; Shi YQ
    Eur J Cancer; 2014 Jul; 50(10):1772-1778. PubMed ID: 24768330
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Gastrointestinal stromal tumour: our experience].
    Versaci A; Macrì A; Ieni A; Terranova M; Leonello G; Saladino E; Speciale G; Famulari C
    Chir Ital; 2009; 61(2):161-9. PubMed ID: 19536989
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Morphology of gastrointestinal stromal tumors in advanced stages of the disease: baseline findings before chemotherapy with imatinib].
    Jost D; Stroszczynski C; Chmelik P; Gaffke G; Schlecht I; Pink D; Reichardt P; Schneider U; Hohenberger P; Felix R
    Rofo; 2003 Jun; 175(6):791-8. PubMed ID: 12811692
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Preoperative imatinib for patients with primary unresectable or metastatic/recurrent gastrointestinal stromal tumor.
    Shen C; Chen H; Yin Y; Chen J; Zhang B; Chen Z; Chen J
    Clinics (Sao Paulo); 2014 Nov; 69(11):758-62. PubMed ID: 25518034
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Imatinib in patients with metastatic gastrointestinal stromal tumours relapsing after hepatic transplantation.
    Bompas E; Boillot O; Bringuier PP; Dumortier J; Blay JY
    Eur J Cancer; 2004 Jun; 40(9):1456-7. PubMed ID: 15177508
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 16.